Joel Morris

1.6k total citations · 1 hit paper
25 papers, 1.1k citations indexed

About

Joel Morris is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Joel Morris has authored 25 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Organic Chemistry, 7 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in Joel Morris's work include Chemical Synthesis and Analysis (5 papers), Synthesis of Organic Compounds (4 papers) and Quinazolinone synthesis and applications (3 papers). Joel Morris is often cited by papers focused on Chemical Synthesis and Analysis (5 papers), Synthesis of Organic Compounds (4 papers) and Quinazolinone synthesis and applications (3 papers). Joel Morris collaborates with scholars based in United States. Joel Morris's co-authors include Donn G. Wishka, Michael R. Barbachyn, Daniel Emmert, Stuart A. Garmon, Judith C. Hamel, Kevin C. Grega, Betty H. Yagi, David R. Graber, Charles W. Ford and Douglas K. Hutchinson and has published in prestigious journals such as Journal of the American Chemical Society, Cancer Research and Advanced Drug Delivery Reviews.

In The Last Decade

Joel Morris

25 papers receiving 1.1k citations

Hit Papers

Substituent Effects on the Antibacterial Activity of Nitr... 2000 2026 2008 2017 2000 200 400 600

Peers

Joel Morris
Zhi‐Jie Ni United States
Wendell Wierenga United States
Kraig M. Yager United States
Neil J. Hales United Kingdom
Sreeman Mamidyala United States
Anthony D. Sercel United States
Paul M. Scola United States
Zhi‐Jie Ni United States
Joel Morris
Citations per year, relative to Joel Morris Joel Morris (= 1×) peers Zhi‐Jie Ni

Countries citing papers authored by Joel Morris

Since Specialization
Citations

This map shows the geographic impact of Joel Morris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel Morris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel Morris more than expected).

Fields of papers citing papers by Joel Morris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel Morris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel Morris. The network helps show where Joel Morris may publish in the future.

Co-authorship network of co-authors of Joel Morris

This figure shows the co-authorship network connecting the top 25 collaborators of Joel Morris. A scholar is included among the top collaborators of Joel Morris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel Morris. Joel Morris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lippa, Blaise, Gonghua Pan, Matthew S. Corbett, et al.. (2008). Synthesis and structure based optimization of novel Akt inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(11). 3359–3363. 64 indexed citations
2.
Jani, Jitesh P., Richard S. Finn, Mary E. Campbell, et al.. (2007). Discovery and Pharmacologic Characterization of CP-724,714, a Selective ErbB2 Tyrosine Kinase Inhibitor. Cancer Research. 67(20). 9887–9893. 62 indexed citations
3.
Lippa, Blaise, Joel Morris, Matthew S. Corbett, et al.. (2006). Discovery of novel isothiazole inhibitors of the TrkA kinase: Structure–activity relationship, computer modeling, optimization, and identification of highly potent antagonists. Bioorganic & Medicinal Chemistry Letters. 16(13). 3444–3448. 36 indexed citations
4.
Bhattacharya, Samit K., Eric Cox, John C. Kath, et al.. (2003). Achieving selectivity between highly homologous tyrosine kinases: a novel selective erbB2 inhibitor. Biochemical and Biophysical Research Communications. 307(2). 267–273. 16 indexed citations
5.
Judge, Thomas M., Joel Morris, Geoffrey P. Luke, et al.. (1997). Asymmetric Syntheses and Absolute Stereochemistry of 5,6-Dihydro-α-pyrones, A New Class of Potent HIV Protease Inhibitors. Journal of the American Chemical Society. 119(15). 3627–3628. 34 indexed citations
6.
Morris, Joel, Donn G. Wishka, George P. Luke, Thomas M. Judge, & Ronald B. Gammill. (1997). A titanium (IV) mediated one-pot double condensation synthesis of 5,6-dihydro-4H-pyran-4-ones. Tetrahedron. 53(32). 11211–11222. 5 indexed citations
7.
Humphrey, William R., Carol A. Simmons, Donn G. Wishka, et al.. (1997). The effect of intramural delivery of polymeric nanoparticles loaded with the antiproliferative 2-aminochromone U-86983 on neointimal hyperplasia development in balloon-injured porcine coronary arteries. Advanced Drug Delivery Reviews. 24(1). 87–108. 16 indexed citations
8.
Morris, Joel, George P. Luke, & Donn G. Wishka. (1996). Reaction of Phosgeniminium Salts with Enolates Derived from Lewis Acid Complexes of 2‘-Hydroxypropiophenones and Related β-Diketones. The Journal of Organic Chemistry. 61(9). 3218–3220. 28 indexed citations
9.
Watenpaugh, Keith David, W. Jeffrey Howe, Paul K. Tomich, et al.. (1995). Structure-Based Design of Nonpeptidic HIV Protease Inhibitors from a Cyclooctylpyranone Lead Structure. Journal of Medicinal Chemistry. 38(22). 4463–4473. 17 indexed citations
10.
Luke, George P. & Joel Morris. (1995). Titanium and Boron Mediated Aldol Reactions of .beta.-Hydroxy Ketones. The Journal of Organic Chemistry. 60(10). 3013–3019. 39 indexed citations
11.
Morris, Joel & Donn G. Wishka. (1995). An Efficient Synthesis of Aromatic Acetonyl Imines. The Journal of Organic Chemistry. 60(8). 2642–2644. 5 indexed citations
12.
Morris, Joel, Donn G. Wishka, & Yue Fang. (1994). A Cyclodehydration Route to 2-Aminochromones. Synthetic Communications. 24(6). 849–858. 17 indexed citations
13.
Morris, Joel & Donn G. Wishka. (1994). Synthesis of 2-Amino-6-phenyl-4H-pyran-4-ones. Synthesis. 1994(1). 43–46. 6 indexed citations
14.
Morris, Joel, Donn G. Wishka, William R. Humphrey, et al.. (1994). Synthesis and biological activity of a potent antiplatelet 7-aminofurochromone. Bioorganic & Medicinal Chemistry Letters. 4(21). 2621–2626. 9 indexed citations
15.
Morris, Joel, Yue Fang, Donn G. Wishka, & Fusen Han. (1993). Synthesis and reactivity of boron difluoride complexes of N,N-dimethylsalicylacetamide. Tetrahedron Letters. 34(24). 3817–3820. 7 indexed citations
16.
Morris, Joel, Donn G. Wishka, & Randy Jensen. (1993). Synthesis of 2,3-dihydro[1]benzopyrano[2,3-b]pyrrol-4(1H)-ones and 1,2,3,4-tetrahydro-5H[1]benzopyrano[2,3-b]pyridin-5-ones. The Journal of Organic Chemistry. 58(25). 7277–7280. 5 indexed citations
17.
Danishefsky, Samuel J., Joel Morris, G. B. MULLEN, & Ronald B. Gammill. (1982). Total synthesis of dl-tazettine and 6a-epipretazettine: a formal synthesis of dl-pretazettine. Some observations on the relationship of 6a-epipretazettine and tazettine. Journal of the American Chemical Society. 104(26). 7591–7599. 19 indexed citations
18.
Danishefsky, Samuel J., Joel Morris, & Lane A. Clizbe. (1981). The Conversion of L-Glutamate to L-Tyrosine. Heterocycles. 15(2). 1205–1205. 4 indexed citations
19.
Danishefsky, Samuel J., Joel Morris, & Lane A. Clizbe. (1981). Total synthesis of pretyrosine (arogenate). Journal of the American Chemical Society. 103(6). 1602–1604. 22 indexed citations
20.
Danishefsky, Samuel J., Joel Morris, G. B. MULLEN, & Ronald B. Gammill. (1980). Total synthesis of dl-tazettine. Journal of the American Chemical Society. 102(8). 2838–2840. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026